Biopharmaceutical
Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye. The company utilizes its proprietary bioresorbable hydrogel-based formulation technology, ELUTYX™, to create drug delivery solutions that reduce the complexity and burden of current standard care. Ocular Therapeutix has built a robust product pipeline and is positioned to become a leader in the ophthalmic space, with particular focus on retinal disease applications.
Beta · Sourced from candidate reports
Be the first to share your experience with Ocular Therapeutix, Inc..
Your reply helps other candidates know what to expect.